Reports

Browse current and previous editions of Switzer Report

Thursday Edition, 1 August 2024
Maureen Jordan

HOT stock: Pro Medicus (PME)

Maureen Jordan · August 1, 2024

In our “HOT” stock column, Michael Gable, managing director of Fairmont Equities, explains why he’s still a buyer of PME for his clients.

Investing Premium
Paul Rickard

Questions of the Week

Paul Rickard · August 1, 2024

How does the EX20 ETF work? Do the brokers see any upside for Cochlear, which is hitting all-time highs? How can I track the prices of the major tech companies such as NVIDIA or Microsoft? What is the last day to buy Rio and get its big fully franked dividend?

Q&A Premium
Monday Edition, 29 July 2024
Paul Rickard

Is Macquarie a buy over $200?

Paul Rickard · July 29, 2024

I’m a great believer in backing track record, so there’s no argument from me when it comes to Macquarie. It is, and remains, a core portfolio stock. The question however is where it sits in the current market: is this a point to acquire more, ease back a touch and take a profit on a small portion, or just sit back?

Investing Premium
James Dunn

4 cancer fighting stocks

James Dunn · July 29, 2024

The ASX has a burgeoning life sciences cohort doing great work in a range of major diseases. Here are four interesting cancer fighters.

Investing Premium
Switzer on Saturday, 27 July 2024
Thursday Edition, 25 July 2024
Maureen Jordan

“HOT” stock: Audinate (ASX:AD8)

Maureen Jordan · July 25, 2024

In our “HOT” stock column, Michael Wayne, Managing Director of Medallion Financial Group, says that for investors who feared they may have missed their chance with Audinate, the current price may present an attractive opportunity to begin accumulating a high-quality growth business during a pull-back.

Investing Premium
Paul Rickard

Questions of the Week

Paul Rickard · July 25, 2024

What do you think of the Qualitas Real Estate Income Fund that’s currently yielding 9%? What about the new ETF BANK, which invests in the debt of the major banks? Is ZIP doing a share purchase plan? What do the broker analysts think of Ampol, which is paying a fully franked yield of over 6%?

Q&A Premium
Monday Edition, 22 July 2024
Peter Switzer

Should we dump HNDQ and tech stocks?

Peter Switzer · July 22, 2024

HNDQ and going long the Nasdaq’s top stocks has been a rewarding play but is it time to take profit and look for another play that will be helped by the rotation out of big tech into smaller growth stocks? As one investing door closes, another one opens, so let’s go looking for a good door for the year ahead.

Investing Premium
1 60 61 62 63 64 116

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.